FORMULA FOR OUR SUCCESS
Kineta is uniquely positioned to leverage its expertise on innate immunity and advance this emerging area of medical research to develop new treatments for infectious, inflammatory and auto immune diseases. Our science has broad pharmaceutical applications to meet the world’s tremendous needs for new antiviral products.

Because we are deeply committed to empowering our scientific team as the architects of our future, Kineta is building a new business model based on thoughtful, incremental growth, deliberate spending and a sophisticated approach to corporate planning; an approach designed to integrate scientific and commercial opportunities. We believe this focus will provide great value to our investors.

We are a privately held corporation that seeks financial partners who share our vision of helping humanity through our robust scientific discovery platform, a sustainable business enterprise and a fresh approach to biotechnology. We encourage medically oriented research foundations, private investors and trusts to learn more about Kineta, Inc. For additional information contact Bill Cadwallader at bcadwallader@kinetabio.com or by calling 206-518-5566.